2-[2-(2,2-dimethylpropanoyl)-5-fluoro-1-benzothien-3-yl]-N,N-diisobutylacetamide | 847804-64-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻吩类
• 英文名称: 2-[2-(2,2-dimethylpropanoyl)-5-fluoro-1-benzothien-3-yl]-N,N-diisobutylacetamide
• 英文别名: 2-[2-(2,2-dimethylpropanoyl)-5-fluoro-1-benzothiophen-3-yl]-N,N-bis(2-methylpropyl)acetamide
• CAS: 847804-64-2
• 化学式: C₂₃H₃₂FNO₂S
• 分子量: 405.577
• InChiKey: WLUSYXXDWZNAFO-UHFFFAOYSA-N

物化性质

• 沸点：
  529.7±50.0 °C(Predicted)
• 密度：
  1.101±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  6.5
• 重原子数：
  28
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  65.6
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• [EN] QUINAZOLINE DERIVATIVES<br/>[FR] DERIVES DE QUINAZOLINE
  申请人：ASTRAZENECA AB

  公开号：WO2005051923A1

  公开（公告）日：2005-06-09

  A quinazoline derivative of the Formula (I): wherein the substituents are as defined in the text for use in the production of an anti proliferative effect which effect is produced alone or in part by inhibiting erbB2 receptor tyrosine kinase in a warm-blooded animal such as man.

  Formula (I)的喹唑啉衍生物：其中取代基如文本中定义的那样，用于生产抗增殖效应，该效应通过在诸如人类等恒温动物中抑制erbB2受体酪氨酸激酶而产生。
• Ophthalmic compositions for treating ocular hypertension
  申请人：Shen Dong-Ming

  公开号：US20060276504A1

  公开（公告）日：2006-12-07

  This invention relates to potent potassium channel blocker compounds of Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans.

  本发明涉及公式I的高效钾通道阻滞剂化合物或其制剂，用于治疗青光眼和其他导致患者眼内压升高的疾病。本发明还涉及使用这些化合物为哺乳动物，特别是人类的眼提供神经保护作用。
• Quinazoline Derivatives
  申请人：Hennequin Francois Andre Laurent

  公开号：US20070244136A1

  公开（公告）日：2007-10-18

  A quinazoline derivative of the Formula (I): wherein the substituents are as defined in the text for use in the production of an anti proliferative effect which effect is produced alone or in part by inhibiting erbB2 receptor tyrosine kinase in a warm-blooded animal such as man.

  一种喹唑啉衍生物，化学式为（I），其中取代基如文本中所定义，用于制备抗增殖效应，该效应仅或部分通过抑制温血动物（例如人）中的erbB2受体酪氨酸激酶产生。
• OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
  申请人：Merck & Co., Inc.

  公开号：EP1664011A2

  公开（公告）日：2006-06-07
• EP1664011A4
  申请人：——

  公开号：EP1664011A4

  公开（公告）日：2009-02-25